JNJ up +0.42% percent Today $JNJ High is at 108.69
Post# of 129
Posted On: 11/17/2014 1:33:41 PM
JNJ up +0.42% percent Today $JNJ High is at 108.69 and the Low 107.61 with current volume of 894,784.
Recent News posted below.
Johnson & Johnson JNJ other info.
http://investorshangout.com/Johnson--Johnson-JNJ-51518/
JNJ Johnson & Johnson Recent Headline News
DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 17 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.30 (+0.14), ABT: 43.90 (+0.09), DXCM: 52.34 (-0.39), MDT: 69.54 (+0.59)
Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.54 (+0.59), BAX: 71.99 (+0.24)
Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)
5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.30 (+0.14), ORLY: 177.64 (-2.24), ED: 62.52 (+0.49), LUV: 39.45 (+0.50), CRM: 62.82 (-1.09)
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.30 (+0.14), GILD: 100.44 (-1.62), ABBV: 65.14 (+1.14), CELG: 104.66 (+0.61)
Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.30 (+0.14), INSY: 38.50 (-0.07), GWPH: 75.31 (-0.32), GSK: 45.93 (+0.19), NVS: 94.54 (+0.59)
Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST
NOV: 71.80 (+0.46), JNJ: 108.30 (+0.14), IBM: 164.48 (+0.32), WMT: 83.51 (+0.55), BAC: 17.07 (-0.07), BEN: 56.30 (-0.08), ACN: 84.69 (+0.05), SLB: 95.98 (+0.66), ORCL: 41.18 (+0.34)
3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 39.99 (+0.62), MMM: 159.04 (+0.19), JNJ: 108.30 (+0.14), LNCO: 20.39 (-0.54), IBM: 164.48 (+0.32), WFC: 53.39 (+0.04), SDRL: 20.86 (+0.08), PG: 87.78 (-0.33), LINE: 22.37 (-0.28), VNR: 23.93 (-0.55), CL: 67.81 (+0.25)
Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.30 (+0.14)
Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST
KO: 42.94 (+0.21), T: 35.90 (unch), JNJ: 108.30 (+0.14), GE: 26.65 (+0.19), XOM: 95.04 (-0.05), MCD: 95.84 (-0.37), PG: 87.77 (-0.34), CVX: 115.98 (-0.34), AAPL: 114.00 (-0.18), WAG: 66.24 (-0.69)
Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)
Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26), AFFX: 9.39 (-0.32)
Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.30 (-0.50), AMZN: 321.03 (-6.79), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), GERN: 3.02 (+0.26), HAL: 49.82 (-5.26), JWN: 73.33 (-0.84), NOK: 7.66 (-0.20), BHI: 66.27 (+6.38)
Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26)
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.39 (+0.28), BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), ACT: 247.01 (+3.24)
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.30 (-0.50), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), VA: 30.98 (+0.98), GERN: 3.02 (+0.26), JWN: 73.33 (-0.84)
Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)
Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)
Recent News posted below.
Johnson & Johnson JNJ other info.
http://investorshangout.com/Johnson--Johnson-JNJ-51518/
JNJ Johnson & Johnson Recent Headline News
DexCom Still A Favorite Diabetes Stock
Bill Gunderson - at Seeking Alpha - 2 hrs 17 mins ago
DexCom (NASDAQ: DXCM ) continues to be one of my favorite diabetes stocks. DexCom, founded in 1999 and based right here in my hometown of San Diego, California, is a medical device company that makes continuous glucose monitoring (CGM) systems. ...
JNJ: 108.30 (+0.14), ABT: 43.90 (+0.09), DXCM: 52.34 (-0.39), MDT: 69.54 (+0.59)
Early Glance: Medical Devices companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 10 a.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.54 (+0.59), BAX: 71.99 (+0.24)
Early Glance: Pharmaceuticals companies
AP - Mon Nov 17, 9:29AM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)
5 Rocket Stocks to Buy as Earnings Season Ends: Southwest Airlines and More
at The Street - Mon Nov 17, 9:17AM CST
From a momentum standpoint, stocks are well-positioned to keep up their upside action as we head into the final stretch of 2014.
JNJ: 108.30 (+0.14), ORLY: 177.64 (-2.24), ED: 62.52 (+0.49), LUV: 39.45 (+0.50), CRM: 62.82 (-1.09)
Why Top Dividend Stock Johnson & Johnson Could Plunge in 2015
George Budwell, The Motley Fool - Motley Fool - Mon Nov 17, 7:13AM CST
As the healthcare sector rolls through its third-quarter earnings, a bucolic picture is coming into focus. Earnings across the sector are soaring due to new drug launches, a frenzy of acquisitions, and vast reorganizations that have helped to stem...
JNJ: 108.30 (+0.14), GILD: 100.44 (-1.62), ABBV: 65.14 (+1.14), CELG: 104.66 (+0.61)
Forget Marijuana! This Is a Much Smarter Investment
Sean Williams, The Motley Fool - Motley Fool - Sun Nov 16, 11:11AM CST
Source: Flickr user Oswaldo. Although marijuana initiatives didn't log a perfect sweep in this year's midterm elections, the momentum behind the legalization movement remains intact. Two states (Oregon and Alaska), as well as Washington, D.C.,...
JNJ: 108.30 (+0.14), INSY: 38.50 (-0.07), GWPH: 75.31 (-0.32), GSK: 45.93 (+0.19), NVS: 94.54 (+0.59)
Value Investors' Most Loved Stocks In Q3 2014
Trading Mates Stock Advisor - at Seeking Alpha - Sun Nov 16, 8:09AM CST
NOV: 71.80 (+0.46), JNJ: 108.30 (+0.14), IBM: 164.48 (+0.32), WMT: 83.51 (+0.55), BAC: 17.07 (-0.07), BEN: 56.30 (-0.08), ACN: 84.69 (+0.05), SLB: 95.98 (+0.66), ORCL: 41.18 (+0.34)
3 Ways High-Yield Dividend Stocks Can Help You Recreate Warren Buffett's Investing Success
Adam Galas, The Motley Fool - Motley Fool - Sat Nov 15, 6:05PM CST
Many people consider Warren Buffett the greatest investor in history and it's not hard to understand why. According to a 2012 Yale study, Buffett's company, Berkshire Hathaway , had the best risk-adjusted return of any company or mutual fund that...
KMI: 39.99 (+0.62), MMM: 159.04 (+0.19), JNJ: 108.30 (+0.14), LNCO: 20.39 (-0.54), IBM: 164.48 (+0.32), WFC: 53.39 (+0.04), SDRL: 20.86 (+0.08), PG: 87.78 (-0.33), LINE: 22.37 (-0.28), VNR: 23.93 (-0.55), CL: 67.81 (+0.25)
Johnson & Johnson Part VI: 'Magic Pants' And 'Doubling Pennies'
Robert Honeywill - Seeking Alpha - Sat Nov 15, 6:00AM CST
In Part V of this series, I provided 4 scenarios (8 Cases) illustrating the potential financial outcomes for investors in Johnson & Johnson (NYSE: JNJ ) under changing PE ratios, which are a reflection of changing share prices and changing...
JNJ: 108.30 (+0.14)
Retirement Strategy: Annuities Vs. Dividend Growth Investing For A Lifetime Income
Regarded Solutions - at Seeking Alpha - Fri Nov 14, 11:01PM CST
KO: 42.94 (+0.21), T: 35.90 (unch), JNJ: 108.30 (+0.14), GE: 26.65 (+0.19), XOM: 95.04 (-0.05), MCD: 95.84 (-0.37), PG: 87.77 (-0.34), CVX: 115.98 (-0.34), AAPL: 114.00 (-0.18), WAG: 66.24 (-0.69)
Final Glance: Pharmaceuticals companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)
Final Glance: Medical Devices companies
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)
Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26), AFFX: 9.39 (-0.32)
Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.30 (-0.50), AMZN: 321.03 (-6.79), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), GERN: 3.02 (+0.26), HAL: 49.82 (-5.26), JWN: 73.33 (-0.84), NOK: 7.66 (-0.20), BHI: 66.27 (+6.38)
Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.30 (+0.14), GERN: 3.02 (+0.26)
Mallinckrodt Shares Down on Setback for Generic Concerta - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 2:39PM CST
Mallinckrodt (MNK) received a setback when the FDA informed the company that its methylphenidate hydrochloride extended-release tablets, USP (CII) might not be therapeutically equivalent to Johnson & Johnson's (JNJ) Concerta.
MNK: 88.39 (+0.28), BIIB: 304.67 (-0.76), JNJ: 108.30 (+0.14), ACT: 247.01 (+3.24)
Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.30 (-0.50), JNJ: 108.30 (+0.14), HTZ: 22.17 (+0.48), VA: 30.98 (+0.98), GERN: 3.02 (+0.26), JWN: 73.33 (-0.84)
Midday Glance: Pharmaceuticals companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top pharmaceuticals companies are down at 1 p.m.:
JNJ: 108.30 (+0.14), BAX: 71.99 (+0.24), PFE: 30.32 (-0.02), BMY: 58.21 (+0.26)
Midday Glance: Medical Devices companies
AP - Fri Nov 14, 12:17PM CST
NEW YORK (AP) — Shares of some top medical devices companies are mixed at 1 p.m.:
ZMH: 110.73 (+0.61), JNJ: 108.30 (+0.14), MDT: 69.53 (+0.58), BAX: 71.99 (+0.24)
(0)
(0)Johnson & Johnson (JNJ) Stock Research Links
Scroll down for more posts ▼